Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration

Title
Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Authors
Keywords
-
Journal
OPHTHALMOLOGY
Volume 123, Issue 1, Pages 70-77.e1
Publisher
Elsevier BV
Online
2015-10-25
DOI
10.1016/j.ophtha.2015.09.002

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started